- Aytu BioPharma (AYTU, Financial) to release fiscal 2025 Q3 results on May 14, 2025, after market close.
- Conference call and webcast scheduled for the same day at 4:30 p.m. Eastern Time.
- Replay of earnings call available until May 28, 2025.
Aytu BioPharma, Inc. (AYTU), a pharmaceutical company specializing in novel therapeutics, has announced the release of its fiscal 2025 third-quarter operational and financial results on May 14, 2025, after the market closes. Investors and analysts are invited to a conference call and webcast scheduled for the same day at 4:30 p.m. Eastern Time. This event will include a comprehensive review of the results, followed by a Q&A session.
Participants can join the conference call by dialing (888) 506-0062 for U.S. callers or +1 (973) 528-0011 for international callers. The access code to join the call is 314386. Additionally, the live and archived webcast will be accessible through the Investors section of Aytu BioPharma's website, providing an alternative method to follow the company's financial updates.
For those unable to attend the live event, a replay of the conference call will be available until May 28, 2025. To access the replay, interested parties can call (877) 481-4010 for domestic callers or +1 (919) 882-2331 for international callers using replay access code 52282. This availability ensures that shareholders and interested parties have ample opportunity to review the detailed discussion of Aytu BioPharma's performance and strategic direction.
